Last 12 months
Inside the activity.
14 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 8 | 5 |
| Apr 2026 | 2 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 30, 2019 Filed Nov 1, 2019 20:10 UTC |
CONLEY SHERYL LDirector
|
GrantCommon Stock | 3,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000377 · edgar.xml · nonDerivative · entry 1 CONLEY SHERYL L · CIK 0001238659 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,244 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) October 30, 2020, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 13:16 UTC |
JAEGER WILFRED EDirector
|
GrantCommon Stock | 1,957 | $8.30 | $16,243.10 |
DisclosureSEC source: 0001209191-19-051999 · doc4.xml · nonDerivative · entry 1 JAEGER WILFRED E · CIK 0001190474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,577 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 13:15 UTC |
CAMPE STEPHEN MDirector
|
GrantCommon Stock | 1,656 | $8.30 | $13,744.80 |
DisclosureSEC source: 0001209191-19-051998 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,410 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is an advisor to an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 20:49 UTC |
Thatcher ChristopherDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-19-048778 · doc4.xml · derivative · entry 3 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,297 Underlying: Common Stock · 20,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 20:49 UTC |
Thatcher ChristopherDirector · President and CEO
|
SaleCommon Stock | 20,000 | $10.74 | $214,700.00 |
DisclosureSEC source: 0001209191-19-048778 · doc4.xml · nonDerivative · entry 2 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,811 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 20:49 UTC |
Thatcher ChristopherDirector · President and CEO
|
Exercise / conversionCommon Stock | 20,000 | $0.87 | $17,400.00 |
DisclosureSEC source: 0001209191-19-048778 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 22:05 UTC |
Harper GregoryVP of R&D, Ops. and Prod. Dev.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,213 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-043415 · doc4.xml · derivative · entry 2 Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,323 Underlying: Common Stock · 19,213 shares Expires 2026-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on September 12, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 22:05 UTC |
Harper GregoryVP of R&D, Ops. and Prod. Dev.
|
Exercise / conversionCommon Stock | 19,213 | $3.19 | $61,289.47 |
DisclosureSEC source: 0001209191-19-043415 · doc4.xml · nonDerivative · entry 1 Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 16:33 UTC |
Furlong StephenCFO and Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 117,845 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001209191-19-043047 · doc4.xml · derivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,845 Underlying: Common Stock · 117,845 shares Expires 2029-07-22 F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on July 22, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 16:33 UTC |
Furlong StephenCFO and Secretary
|
GrantCommon Stock | 60,975 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043047 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,975 F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of July 22, 2020 and July 22, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on July 22, 2022, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:16 UTC |
JAEGER WILFRED EDirector
|
GrantCommon Stock | 1,298 | $12.51 | $16,237.98 |
DisclosureSEC source: 0001209191-19-040460 · doc4.xml · nonDerivative · entry 1 JAEGER WILFRED E · CIK 0001190474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,620 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 21:15 UTC |
CAMPE STEPHEN MDirector
|
GrantCommon Stock | 1,099 | $12.51 | $13,748.49 |
DisclosureSEC source: 0001209191-19-040453 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,754 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc. (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:50 UTC |
MUIR GLENN PDirector
|
GrantStock Option (right to buy) · Derivative | 7,347 | $0.00 Strike: $13.43 | $0.00 |
DisclosureSEC source: 0001209191-19-033453 · doc4.xml · derivative · entry 2 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Underlying: Common Stock · 7,347 shares Expires 2029-05-27 F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:50 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 3,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-033453 · doc4.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,723 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:47 UTC |
Blanchard Cheryl RDirector
|
GrantStock Option (right to buy) · Derivative | 7,347 | $0.00 Strike: $13.43 | $0.00 |
DisclosureSEC source: 0001209191-19-033450 · doc4.xml · derivative · entry 2 Blanchard Cheryl R · CIK 0001326530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Underlying: Common Stock · 7,347 shares Expires 2029-05-27 F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:47 UTC |
Blanchard Cheryl RDirector
|
GrantCommon Stock | 3,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-033450 · doc4.xml · nonDerivative · entry 1 Blanchard Cheryl R · CIK 0001326530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,437 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:51 UTC |
CAMPE STEPHEN MDirector
|
GrantStock Option (right to buy) · Derivative | 7,347 | $0.00 Strike: $13.43 | $0.00 |
DisclosureSEC source: 0001209191-19-033455 · doc4.xml · derivative · entry 2 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Underlying: Common Stock · 7,347 shares Expires 2029-05-27 F6 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F3 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F4 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F5 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:51 UTC |
CAMPE STEPHEN MDirector
|
GrantCommon Stock | 3,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-033455 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,655 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F4 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F5 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:49 UTC |
Farley Brian EDirector
|
GrantStock Option (right to buy) · Derivative | 7,347 | $0.00 Strike: $13.43 | $0.00 |
DisclosureSEC source: 0001209191-19-033452 · doc4.xml · derivative · entry 2 Farley Brian E · CIK 0001306117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Underlying: Common Stock · 7,347 shares Expires 2029-05-27 F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:49 UTC |
Farley Brian EDirector
|
GrantCommon Stock | 5,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-033452 · doc4.xml · nonDerivative · entry 1 Farley Brian E · CIK 0001306117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,606 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:48 UTC |
JAEGER WILFRED EDirector
|
GrantStock Option (right to buy) · Derivative | 7,347 | $0.00 Strike: $13.43 | $0.00 |
DisclosureSEC source: 0001209191-19-033451 · doc4.xml · derivative · entry 2 JAEGER WILFRED E · CIK 0001190474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,347 Underlying: Common Stock · 7,347 shares Expires 2029-05-27 F3 · derivative.exercise_date: The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:48 UTC |
JAEGER WILFRED EDirector
|
GrantCommon Stock | 3,723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-033451 · doc4.xml · nonDerivative · entry 1 JAEGER WILFRED E · CIK 0001190474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,322 F1 · shares: Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 22, 2019 Filed May 23, 2019 20:54 UTC |
Guthrie DanielChief Commercial Officer
|
SaleCommon Stock | 3,685 | $14.53 | $53,543.05 |
DisclosureSEC source: 0001209191-19-032311 · doc4.xml · nonDerivative · entry 1 Guthrie Daniel · CIK 0001744934 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,574 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.30 to $14.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote (1) to this Form 4. Read SEC document |
| May 14, 2019 Filed May 14, 2019 17:49 UTC |
Donato PeterVice President and CFO
|
SaleCommon Stock | 8,032 | $14.90 | $119,676.80 |
DisclosureSEC source: 0001209191-19-029741 · doc4.xml · nonDerivative · entry 2 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,987 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.445 to $15.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 13, 2019 Filed May 14, 2019 17:49 UTC |
Donato PeterVice President and CFO
|
SaleCommon Stock | 563 | $15.40 | $8,670.20 |
DisclosureSEC source: 0001209191-19-029741 · doc4.xml · nonDerivative · entry 1 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,019 Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
SaleCommon Stock | 706 | $15.30 | $10,801.80 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 6 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,582 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.435 inclusive. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 24,051 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 9 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,662 Underlying: Common Stock · 24,051 shares Expires 2027-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,672 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 8 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,014 Underlying: Common Stock · 7,672 shares Expires 2028-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on March 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,905 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · derivative · entry 7 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,667 Underlying: Common Stock · 6,905 shares Expires 2027-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
SaleCommon Stock | 1,878 | $15.67 | $29,428.26 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 5 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,288 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.50 to $15.935 inclusive. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
SaleCommon Stock | 20,469 | $15.23 | $311,742.87 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 4 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,166 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $15.4925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionCommon Stock | 24,051 | $3.19 | $76,722.69 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 3 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionCommon Stock | 7,672 | $4.64 | $35,598.08 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 2 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2019 Filed May 13, 2019 18:33 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionCommon Stock | 6,905 | $2.32 | $16,019.60 |
DisclosureSEC source: 0001209191-19-029440 · doc4.xml · nonDerivative · entry 1 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 21:37 UTC |
Farley Brian EDirector
|
GrantCommon Stock | 1,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-026015 · doc4.xml · nonDerivative · entry 1 Farley Brian E · CIK 0001306117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,022 F1 · kind: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of July 26, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service. F2 · price: Each RSU represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 22, 2019 Filed Apr 23, 2019 20:55 UTC |
Harper GregoryVP of R&D, Ops. and Prod. Dev.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-025592 · doc4.xml · derivative · entry 2 Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,536 Underlying: Common Stock · 35,000 shares Expires 2026-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on September 12, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| April 22, 2019 Filed Apr 23, 2019 20:55 UTC |
Harper GregoryVP of R&D, Ops. and Prod. Dev.
|
Exercise / conversionCommon Stock | 35,000 | $3.19 | $111,650.00 |
DisclosureSEC source: 0001209191-19-025592 · doc4.xml · nonDerivative · entry 1 Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 22:26 UTC |
Thatcher ChristopherDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-19-024035 · doc4.xml · derivative · entry 3 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,297 Underlying: Common Stock · 15,000 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 22:26 UTC |
Thatcher ChristopherDirector · President and CEO
|
SaleCommon Stock | 15,000 | $16.82 | $252,300.00 |
DisclosureSEC source: 0001209191-19-024035 · doc4.xml · nonDerivative · entry 2 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,811 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.545 to $16.955 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 22:26 UTC |
Thatcher ChristopherDirector · President and CEO
|
Exercise / conversionCommon Stock | 15,000 | $0.87 | $13,050.00 |
DisclosureSEC source: 0001209191-19-024035 · doc4.xml · nonDerivative · entry 1 Thatcher Christopher · CIK 0001744956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 17:31 UTC |
HUNT RONALDDirector · 10% owner
|
GrantCommon Stock | 847 | $14.75 | $12,493.25 |
DisclosureSEC source: 0001209191-19-023352 · doc4.xml · nonDerivative · entry 1 HUNT RONALD · CIK 0001247851 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 847 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:34 UTC |
JAEGER WILFRED EDirector
|
GrantCommon Stock | 932 | $14.75 | $13,747.00 |
DisclosureSEC source: 0001209191-19-023362 · doc4.xml · nonDerivative · entry 1 JAEGER WILFRED E · CIK 0001190474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,599 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:32 UTC |
CAMPE STEPHEN MDirector
|
GrantCommon Stock | 932 | $14.75 | $13,747.00 |
DisclosureSEC source: 0001209191-19-023358 · doc4.xml · nonDerivative · entry 1 CAMPE STEPHEN M · CIK 0001206614 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,932 F1 · kind: Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer. F2 · ownership.direct: Mr. Stephen M. Campe is a senior executive employee of an affiliate of Investor Growth Capital, LLC ("Investor"). Investor, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934 (the "Act"), separately reports its holdings with respect to the securities of Neuronetics, Inc.'s (the "Issuer"). F3 · ownership.direct: Pursuant to Rule 13d-4 under the Act, Mr. Campe disclaims beneficial ownership of any of the Issuer's securities held by Investor. Moreover, Mr. Campe disclaims group membership with Investor (or any other entity or person) for the purposes of Section 13(d) of the Act, or for any other purpose. F4 · ownership.direct: Mr. Campe's interest in all of the Issuer's securities is limited to the extent of his pecuniary interest in such securities, if any, and neither the filing of this statement nor any of its contents will be deemed to constitute an admission by Mr Campe or any other person/entity, that he or it was, or is, the beneficial owner of any of the Issuer's securities for purposes of Section 16 of the Act, or for any other purpose. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC |
Donato PeterVice President and CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,652 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 8 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,652 Underlying: Common Stock · 24,652 shares Expires 2029-03-08 F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,177 | $0.00 Strike: $3.19 | $0.00 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · derivative · entry 7 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,713 Underlying: Common Stock · 8,177 shares Expires 2027-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC |
Donato PeterVice President and CFO
|
GrantCommon Stock | 14,007 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 5 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,007 F3 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC |
Donato PeterVice President and CFO
|
SaleCommon Stock | 8,177 | $16.01 | $130,913.77 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 4 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.085 inclusive. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 19:11 UTC |
Donato PeterVice President and CFO
|
Exercise / conversionCommon Stock | 8,177 | $3.19 | $26,084.63 |
DisclosureSEC source: 0001209191-19-018606 · doc4.xml · nonDerivative · entry 3 Donato Peter · CIK 0001408320 · Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:13 UTC |
Harper GregoryVP of R&D, Ops. and Prod. Dev.
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,829 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001209191-19-018612 · doc4.xml · derivative · entry 2 Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,829 Underlying: Common Stock · 19,829 shares Expires 2029-03-08 F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:13 UTC |
Harper GregoryVP of R&D, Ops. and Prod. Dev.
|
GrantCommon Stock | 11,267 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018612 · doc4.xml · nonDerivative · entry 1 Harper Gregory · CIK 0001744952 · VP of R&D, Ops. and Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,267 F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.